These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

506 related items for PubMed ID: 11119911

  • 21. Impact of OKT3 treatment for steroid resistant rejection of renal allografts: the long-term outcome at a single center.
    Inui M, Tanabe K, Ishikawa N, Tokumoto T, Harano M, Otsubo S, Suzuki K, Goya N, Yagisawa T, Nakazawa H, Fuchinoue S, Toma H.
    Transplant Proc; 1999 Nov; 31(7):2870-1. PubMed ID: 10578320
    [No Abstract] [Full Text] [Related]

  • 22. Effect of tacrolimus in renal transplant recipients with immunoglobulin-A nephropathy.
    Suzuki K, Tanabe K, Tokumoto T, Shimizu T, Ishikawa N, Yagisawa T, Honda K, Nihei H, Toma H.
    Transplant Proc; 2000 Nov; 32(7):1730-2. PubMed ID: 11119910
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Long-term results after primary successful FK 506 treatment of steroid- and OKT3-resistant rejection in renal transplant recipients.
    Kliem V, Schaumann D, Ehlerding G, Eberhard OK, Lufft V, Schlitt HJ, Pichlmayr R, Koch KM, Brunkhorst R.
    Transplant Proc; 1997 Nov; 29(7):2955-7. PubMed ID: 9365627
    [No Abstract] [Full Text] [Related]

  • 25. Efficacy and safety of mycophenolate mofetil in different dosages in Asian renal allograft recipients.
    Tsang WK, Tong KL, Yeung S, Lee W, Chan HW.
    Transplant Proc; 2000 Nov; 32(7):1755-6. PubMed ID: 11119921
    [No Abstract] [Full Text] [Related]

  • 26. Long-term outcome of cadaveric kidney grafts with triple drug therapy.
    Amemiya H, Suzuki S, Hayashi R, Nakatani T.
    Transplant Proc; 1994 Aug; 26(4):2097-8. PubMed ID: 8066683
    [No Abstract] [Full Text] [Related]

  • 27. Correlation of clinical outcomes after tacrolimus conversion for resistant kidney rejection or cyclosporine toxicity with pathologic staging by the Banff criteria.
    Morrissey PE, Gohh R, Shaffer D, Crosson A, Madras PN, Sahyoun AI, Monaco AP.
    Transplantation; 1997 Mar 27; 63(6):845-8. PubMed ID: 9089224
    [Abstract] [Full Text] [Related]

  • 28. The use of tacrolimus as induction and maintenance immunosuppression in renal cadaveric transplant recipients over the age of 60.
    Xenos EX, Ciancio G, Burke GW, Roth D, Miller J.
    Clin Transplant; 1997 Oct 27; 11(5 Pt 2):497-9. PubMed ID: 9361949
    [Abstract] [Full Text] [Related]

  • 29. OKT3 versus methylprednisolone for primary treatment of rejection: a retrospective evaluation.
    Meijer RT, Keur I, Surachno S, ten Berge IJ, Schellekens PT.
    Transplant Proc; 2001 May 27; 33(3):2196-7. PubMed ID: 11377501
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Effectiveness of short-term OKT3 therapy in the treatment of steroid-resistant renal allograft rejection.
    Carvalho MF, Adoni T, Saggioro FP, Soares V.
    Transplant Proc; 1998 Sep 27; 30(6):2876-7. PubMed ID: 9745607
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Primary tacrolimus-based immunosuppression in renal allograft recipients: a single center experience.
    Lye WC.
    Transplant Proc; 2000 Nov 27; 32(7):1700-1. PubMed ID: 11119898
    [No Abstract] [Full Text] [Related]

  • 34. Impact of tacrolimus on hyperlipidemia after renal transplantation: a Japanese single center experience.
    Manu M, Tanabe K, Tokumoto T, Ishikawa N, Shimizu T, Okuda H, Ito S, Shimmura H, Inui M, Harano M, Shiroyanagi Y, Yagisawa T, Fuchinoue S, Toma H.
    Transplant Proc; 2000 Nov 27; 32(7):1736-8. PubMed ID: 11119912
    [No Abstract] [Full Text] [Related]

  • 35. Evaluation of various immunosuppressive regimes in second renal transplants.
    Toronyi E, Remport A, Járay J, Máthé Z, Borka P, Perner F.
    Transplant Proc; 2001 May 27; 33(3):2315-6. PubMed ID: 11377543
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Tacrolimus (FK 506) therapy in simultaneous pancreas kidney transplantation.
    Becker G, Witzke O, Friedrich J, Wagner K, Heemann U, Philipp T.
    Transplant Proc; 1996 Dec 27; 28(6):3169-70. PubMed ID: 8962228
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. A large, multicentre trial to compare the efficacy and safety of tacrolimus with cyclosporine microemulsion following renal transplantation.
    Sperschneider H, European Renal Transplantation Study Group.
    Transplant Proc; 2001 Dec 27; 33(1-2):1279-81. PubMed ID: 11267291
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 26.